110 related articles for article (PubMed ID: 7721406)
1. Effectiveness of enalapril versus nifedipine to antagonize blood pressure and the renal response to endothelin in humans.
Kaasjager KA; Koomans HA; Rabelink TJ
Hypertension; 1995 Apr; 25(4 Pt 1):620-5. PubMed ID: 7721406
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1-induced vasopressor responses in essential hypertension.
Kaasjager KA; Koomans HA; Rabelink TJ
Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
[TBL] [Abstract][Full Text] [Related]
3. Interactions of nifedipine with the renovascular effects of endothelin in humans.
Kaasjager KA; van Rijn HJ; Koomans HA; Rabelink TJ
J Pharmacol Exp Ther; 1995 Oct; 275(1):306-11. PubMed ID: 7562563
[TBL] [Abstract][Full Text] [Related]
4. L-arginine does not prevent the renal effects of endothelin in humans.
Bijlsma JA; Rabelink AJ; Kaasjager KA; Koomans HA
J Am Soc Nephrol; 1995 Jan; 5(7):1508-16. PubMed ID: 7703389
[TBL] [Abstract][Full Text] [Related]
5. Effects of endothelin-1 on renal function in humans: implications for physiology and pathophysiology.
Rabelink TJ; Kaasjager KA; Boer P; Stroes EG; Braam B; Koomans HA
Kidney Int; 1994 Aug; 46(2):376-81. PubMed ID: 7967349
[TBL] [Abstract][Full Text] [Related]
6. Vascular actions of endothelin in the rabbit kidney.
Denton KM; Anderson WP
Clin Exp Pharmacol Physiol; 1990 Dec; 17(12):861-72. PubMed ID: 2092953
[TBL] [Abstract][Full Text] [Related]
7. Effects of antihypertensive drugs on autoregulation of RBF and glomerular capillary pressure in SHR.
Kvam FI; Ofstad J; Iversen BM
Am J Physiol; 1998 Oct; 275(4):F576-84. PubMed ID: 9755129
[TBL] [Abstract][Full Text] [Related]
8. Nifedipine attenuates systemic and renal vasoconstriction during nitric oxide inhibition in humans.
Dijkhorst-Oei LT; Rabelink TJ; Boer P; Koomans HA
Hypertension; 1997 May; 29(5):1192-8. PubMed ID: 9149686
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
[TBL] [Abstract][Full Text] [Related]
10. [Protective effect of a calcium antagonist against renal vasoconstriction induced by endothelin in the normotensive rat].
Madeddu P; Pala F; Troffa C; Pinna Parpaglia P; Pazzola A; Soro A; Manunta P; Tonolo G; Melis MG; Demontis MP
Boll Soc Ital Biol Sper; 1990 Jul; 66(7):671-8. PubMed ID: 2083061
[TBL] [Abstract][Full Text] [Related]
11. Effects of angiotensin II on renal sodium handling and diluting capacity in man pretreated with high-salt diet and enalapril.
Vos PF; Koomans HA; Boer P; Dorhout Mees EJ
Nephrol Dial Transplant; 1992; 7(10):991-6. PubMed ID: 1331894
[TBL] [Abstract][Full Text] [Related]
12. Effects of enalapril and eprosartan on the renal vascular nitric oxide system in human essential hypertension.
Delles C; Jacobi J; John S; Fleischmann I; Schmieder RE
Kidney Int; 2002 Apr; 61(4):1462-8. PubMed ID: 11918753
[TBL] [Abstract][Full Text] [Related]
13. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-A receptors mediate renal hemodynamic effects of exogenous Angiotensin II in humans.
Montanari A; Biggi A; Carra N; Ziliotti M; Fasoli E; Musiari L; Perinotto P; Novarini A
Hypertension; 2003 Oct; 42(4):825-30. PubMed ID: 12925560
[TBL] [Abstract][Full Text] [Related]
15. Effects of the calcium channel antagonist nicardipine on renal action of endothelin in dogs.
Yukimura T; Miura K; Yamashita Y; Shimmen T; Okumura M; Yamanaka S; Saito M; Yamamoto K
Contrib Nephrol; 1991; 90():105-10. PubMed ID: 1959334
[TBL] [Abstract][Full Text] [Related]
16. Adverse effect of the calcium channel blocker nitrendipine on nephrosclerosis in rats with renovascular hypertension.
Wenzel UO; Troschau G; Schoeppe W; Helmchen U; Schwietzer G
Hypertension; 1992 Aug; 20(2):233-41. PubMed ID: 1639466
[TBL] [Abstract][Full Text] [Related]
17. The angiotensin converting enzyme inhibitor enalapril and its effects on renal function.
de Zeeuw D; Navis GJ; Donker AJ; de Jong PE
J Hypertens Suppl; 1983 Oct; 1(1):93-7. PubMed ID: 6100614
[TBL] [Abstract][Full Text] [Related]
18. Big ET-1 infusion in man causes renal ET-1 release, renal and splanchnic vasoconstriction, and increased mean arterial blood pressure.
Ahlborg G; Ottosson-Seeberger A; Hemsén A; Lundberg JM
Cardiovasc Res; 1994 Oct; 28(10):1559-63. PubMed ID: 8001046
[TBL] [Abstract][Full Text] [Related]
19. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats.
Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM
Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of intravenous cyclosporine on blood pressure, renal hemodynamics, and urine prostaglandin production of healthy humans.
Weir MR; Klassen DK; Shen SY; Sullivan D; Buddemeyer EU; Handwerger BS
Transplantation; 1990 Jan; 49(1):41-7. PubMed ID: 2301025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
